Abonnement à la biblothèque: Guest
Critical Reviews™ in Immunology

Publication de 6  numéros par an

ISSN Imprimer: 1040-8401

ISSN En ligne: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Accéder(open in a new tab)
Suite
Achat $35.00(open in a new tab) Vérifier l'abonnement Télécharger l'archive MARC(open in a new tab) Obtenir des autorisations(open in a new tab)

Autoimmunity and the Immunotherapy of Cancer: Targeting the "Self" to Destroy the "Other"

Volume 20, Numéro 6, 2000, 18 pages
DOI: 10.1615/CritRevImmunol.v20.i6.10
Get accessGet access
Willem W. Overwijk
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
Nicholas P. Restifo
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

RÉSUMÉ

It is increasingly clear that immunity to "self-antigens may result in tumor destruction in mouse and man. But which antigens should be targeted with therapeutic cancer vaccines? In the case of melanoma, recognition of melanocyte differentiation antigens (MDA) can be associated with autoimmune depigmentation (vitiligo). We propose that intersection of protein transport to melanosomes and endosomes allows for the loading of MDA-derived peptides on MHC class II molecules, resulting in the activation of MDA-specific CD4+ "helper" T cells that aid the induction of melanoma-specific CD8+ T cells. Thus, the immunogenicity of MDA may be a consequence of their unique cell biology. Studies of MDA-based vaccines can provide new insight into the development of more effective cancer vaccines.

CITÉ PAR

  1. Poust Jamie C., Woolery Joseph E., Green Myke R., Management of toxicities associated with high-dose interleukin-2 and biochemotherapy, Anti-Cancer Drugs, 24, 1, 2013. Crossref

  2. Dummer Wolfgang, Niethammer Andreas G., Baccala Roberto, Lawson Brian R., Wagner Norbert, Reisfeld Ralph A., Theofilopoulos Argyrios N., T cell homeostatic proliferation elicits effective antitumor autoimmunity, Journal of Clinical Investigation, 110, 2, 2002. Crossref

  3. Moschos Stergios J., Konstantinopoulos Panagiotis A., Kirkwood John M., , 22, 2005. Crossref

  4. Antony Paul Andrew, Restifo Nicholas P, CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2, Journal of Immunotherapy, 28, 2, 2005. Crossref

  5. Dummer Wolfgang, Niethammer Andreas G., Baccala Roberto, Lawson Brian R., Wagner Norbert, Reisfeld Ralph A., Theofilopoulos Argyrios N., T cell homeostatic proliferation elicits effective antitumor autoimmunity, Journal of Clinical Investigation, 110, 2, 2002. Crossref

  6. Capone Giovanni, Lucchese Guglielmo, Calabrò Michele, Kanduc Darja, West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses, Immunopharmacology and Immunotoxicology, 35, 1, 2013. Crossref

  7. Kanduc Darja, Homology, similarity, and identity in peptide epitope immunodefinition, Journal of Peptide Science, 18, 8, 2012. Crossref

  8. Nichols Sarah E., Harper Dawn C., Berson Joanne F., Marks Michael S., A Novel Splice Variant of Pmel17 Expressed by Human Melanocytes and Melanoma Cells Lacking Some of the Internal Repeats, Journal of Investigative Dermatology, 121, 4, 2003. Crossref

  9. Le poole I. Caroline, Wañkowicz-kaliñska Anna, van den Wijngaard René MJGJ, Nickoloff Brian J., Das Pranab K., Autoimmune Aspects of Depigmentation in Vitiligo, Journal of Investigative Dermatology Symposium Proceedings, 9, 1, 2004. Crossref

  10. Hartmann T.B., Thiel D., Dummer R., Schadendorf D., Eichmuller S., SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma, British Journal of Dermatology, 150, 2, 2004. Crossref

  11. Vacchelli Erika, Vitale Ilio, Eggermont Alexander, Fridman Wolf Hervé, Fučíková Jitka, Cremer Isabelle, Galon Jérôme, Tartour Eric, Zitvogel Laurence, Kroemer Guido, Galluzzi Lorenzo, Trial watch, OncoImmunology, 2, 10, 2013. Crossref

  12. Dummer Wolfgang, Niethammer Andreas G., Baccala Roberto, Lawson Brian R., Wagner Norbert, Reisfeld Ralph A., Theofilopoulos Argyrios N., T cell homeostatic proliferation elicits effective antitumor autoimmunity, Journal of Clinical Investigation, 110, 2, 2002. Crossref

  13. Naveh Hadas Prag, Rao Uma N. M., Butterfield Lisa H., Melanoma-associated leukoderma - immunology in black and white?, Pigment Cell & Melanoma Research, 26, 6, 2013. Crossref

  14. Bridle Byram W, Chen Lan, Lemay Chantal G, Diallo Jean-Simon, Pol Jonathan, Nguyen Andrew, Capretta Alfredo, He Rongqiao, Bramson Jonathan L, Bell John C, Lichty Brian D, Wan Yonghong, HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy, Molecular Therapy, 21, 4, 2013. Crossref

  15. Borovansk?? Jan, Hor??k Vratislav, Elleder Milan, Fort??n Karel, Smit Nico PM, Kolb Adriana M, Biochemical characterization of a new melanoma model ??? the minipig MeLiM strain, Melanoma Research, 13, 6, 2003. Crossref

  16. Olie Robert A., Hafner Christoph, Küttel Renzo, Sigrist Brigitte, Stahel Rolf A., Zangemeister-Wittke Uwe, Willers Jörg, Dummer Reinhard, Hall Jonathan, Bcl-2 and bcl-xL Antisense Oligonucleotides Induce Apoptosis in Melanoma Cells of Different Clinical Stages, Journal of Investigative Dermatology, 118, 3, 2002. Crossref

  17. Norval M., Cullen A. P., de Gruijl F. R., Longstreth J., Takizawa Y., Lucas R. M., Noonan F. P., van der Leun J. C., The effects on human health from stratospheric ozone depletion and its interactions with climate change, Photochemical & Photobiological Sciences, 6, 3, 2007. Crossref

  18. Dy Grace K., Adjei Alex A., Systemic cancer therapy: Evolution over the last 60 years, Cancer, 113, S7, 2008. Crossref

  19. Ciesielski Michael J., Ahluwalia Manmeet S., Munich Stephan A., Orton Molly, Barone Tara, Chanan-Khan Asher, Fenstermaker Robert A., Antitumor cytotoxic T-cell response induced by a survivin peptide mimic, Cancer Immunology, Immunotherapy, 59, 8, 2010. Crossref

  20. Smith Franz O., Klapper Jacob A., Wunderlich John R., Rosenberg Steven A., Dudley Mark E., Impact of a Recombinant Fowlpox Vaccine on the Efficacy of Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes in a Patient With Metastatic Melanoma, Journal of Immunotherapy, 32, 8, 2009. Crossref

  21. Wankowicz-Kalinska Anna, Le poole Caroline, Van Den Wijngaard Rene, Storkus Walter J., Das Pranab K., Melanocyte-Specific Immune Response in Melanoma and Vitiligo: Two Faces of the Same Coin?, Pigment Cell Research, 16, 3, 2003. Crossref

  22. Goldstein Oliver G., Hajiaghamohseni Laela M., Amria Shereen, Sundaram Kumaran, Reddy Sakamuri V., Haque Azizul, Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma, Cancer Immunology, Immunotherapy, 57, 10, 2008. Crossref

  23. Fenstermaker Robert A, Ciesielski Michael J, Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma, Expert Review of Vaccines, 13, 3, 2014. Crossref

  24. Hartmann Tanja B., Bazhin Alexandr V., Schadendorf Dirk, Eichmüller Stefan B., SEREX identification of new tumor antigens linked to melanoma-associated retinopathy, International Journal of Cancer, 114, 1, 2005. Crossref

  25. Rizza Paola, Moretti Franca, Belardelli Filippo, Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity, Autoimmunity, 43, 3, 2010. Crossref

  26. Weber Jeffrey, Immunotherapy for melanoma, Current Opinion in Oncology, 23, 2, 2011. Crossref

  27. Elsawa Sherine F, Rodeberg David A, Celis Esteban, T-cell epitope peptide vaccines, Expert Review of Vaccines, 3, 5, 2004. Crossref

  28. Egorov Igor K., Mouse models of efficient and inefficient anti-tumor immunity, with emphasis on minimal residual disease and tumor escape, Cancer Immunology, Immunotherapy, 55, 1, 2006. Crossref

  29. Oyarbide-Valencia Kepa, van den Boorn Jasper G., Denman Cecele J., Li Mingli, Carlson Jeremy M., Hernandez Claudia, Nishimura Michael I., Das Pranab K., Luiten Rosalie M., Le Poole I. Caroline, Therapeutic implications of autoimmune vitiligo T cells, Autoimmunity Reviews, 5, 7, 2006. Crossref

  30. Buteau Chantal, Markovic Svetomir N., Celis Esteban, Challenges in the Development of Effective Peptide Vaccines for Cancer, Mayo Clinic Proceedings, 77, 4, 2002. Crossref

  31. Sela Michael, Arnon Ruth, Schechter Bilha, Therapeutic vaccines: realities of today and hopes for the future, Drug Discovery Today, 7, 12, 2002. Crossref

  32. Restifo Nicholas P., Dudley Mark E., Rosenberg Steven A., Adoptive immunotherapy for cancer: harnessing the T cell response, Nature Reviews Immunology, 12, 4, 2012. Crossref

  33. Ferrantini Maria, Capone Imerio, Belardelli Filippo, Interferon-α and cancer: Mechanisms of action and new perspectives of clinical use, Biochimie, 89, 6-7, 2007. Crossref

  34. Träger Ulrike, Sierro Sophie, Djordjevic Gordana, Bouzo Basma, Khandwala Shivani, Meloni Antonella, Mortensen Monika, Simon Anna Katharina, Cohen Irun R., The Immune Response to Melanoma Is Limited by Thymic Selection of Self-Antigens, PLoS ONE, 7, 4, 2012. Crossref

  35. Fenstermaker Robert A., Ciesielski Michael J., Qiu Jingxin, Yang Nuo, Frank Cheryl L., Lee Kelvin P., Mechtler Laszlo R., Belal Ahmed, Ahluwalia Manmeet S., Hutson Alan D., Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma, Cancer Immunology, Immunotherapy, 65, 11, 2016. Crossref

  36. Blagosklonny M V, Tissue-selective therapy of cancer, British Journal of Cancer, 89, 7, 2003. Crossref

  37. SURIANO ROBERT, RAJORIA SHILPI, GEORGE ANDREA L., GELIEBTER JAN, TIWARI RAJ K., WALLACK MARC, Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma, Molecular and Clinical Oncology, 1, 3, 2013. Crossref

  38. Sanmamed Miguel F., Chen Lieping, A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization, Cell, 175, 2, 2018. Crossref

  39. Cruz Michelle S., Diamond Alani, Russell Astrid, Jameson Julie Marie, Human αβ and γδ T Cells in Skin Immunity and Disease, Frontiers in Immunology, 9, 2018. Crossref

  40. Sun Weihong, Shi Junyi, Wu Jian, Zhang Junchu, Chen Huabiao, Li Yuanyuan, Liu Shuxun, Wu Yanfeng, Tian Zhigang, Cao Xuetao, Li Nan, A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses, Cellular & Molecular Immunology, 15, 8, 2018. Crossref

  41. Nordlund James J., Le Caroline I. Poole, Boissy Raymond E., Vitiligo Vulgaris, in Clinical and Basic Immunodermatology, 2008. Crossref

  42. Puttick Simon, Boase Nathan R.B., Blakey Idriss, Thurecht Kristofer J., Imaging tumour distribution of a polymeric drug delivery platformin vivoby PET-MRI, Journal of Chemical Technology & Biotechnology, 90, 7, 2015. Crossref

  43. Margolis Naama, Markovits Ettai, Markel Gal, Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy, Advanced Drug Delivery Reviews, 141, 2019. Crossref

  44. Dy Grace K., Adjei Alex A., Obtacles and opportunities in the clinical development of targeted therapeutics, in Advances in Targeted Cancer Therapy, 63, 2005. Crossref

  45. Chesson Charles B, Zloza Andrew, Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer, Nanomedicine, 12, 23, 2017. Crossref

  46. Winograd Evan K, Ciesielski Michael J, Fenstermaker Robert A, Novel vaccines for glioblastoma: clinical update and perspective, Immunotherapy, 8, 11, 2016. Crossref

  47. Blagosklonny Mikhail V, Prospective strategies to enforce selectively cell death in cancer cells, Oncogene, 23, 16, 2004. Crossref

  48. O InSug, Blaszczyk-Thurin Magdalena, Shen Chunpang T, Ertl Hildegund CJ, A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma, Cancer Gene Therapy, 10, 9, 2003. Crossref

  49. Grant Melanie L, Shields Nicholas, Neumann Silke, Kramer Katrin, Bonato Andrea, Jackson Christopher, Baird Margaret A, Young Sarah L, Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8 + T cells , Clinical & Translational Immunology, 6, 7, 2017. Crossref

  50. Mu Qingxin, Lin Guanyou, Stephen Zachary R., Chung Seokhwan, Wang Hui, Patton Victoria K., Gebhart Rachel N., Zhang Miqin, In vivo serum enabled production of ultrafine nanotherapeutics for cancer treatment, Materials Today, 38, 2020. Crossref

  51. Antony Paul A., Piccirillo Ciriaco A., Akpinarli Akgül, Finkelstein Steven E., Speiss Paul J., Surman Deborah R., Palmer Douglas C., Chan Chi-Chao, Klebanoff Christopher A., Overwijk Willem W., Rosenberg Steven A., Restifo Nicholas P., CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells, The Journal of Immunology, 174, 5, 2005. Crossref

660 Vues d'articles 17 Téléchargements d'articles Métrique
660 VUES 17 TÉLÉCHARGEMENTS 51 Crossref CITATIONS Google
Scholar CITATIONS

Articles avec un contenu similaire:

Improving Immunotherapy by Conditionally Enhancing MHC Class I Presentation of Tumor Antigen-Derived Peptide Epitopes Critical Reviews™ in Immunology, Vol.27, 2007, issue 5
Ronald M. Bukowski, Mayumi Kawabe, Peter A. Cohen, James H. Finke, Amy K. Wesa, Walter J. Storkus, Christopher Herrem
NK Cells in Therapy of Cancer Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 1-2
Veronika Bachanova, Jeffrey S. Miller
Regulation of NK Cell Repertoire and Function in the Liver Critical Reviews™ in Immunology, Vol.31, 2011, issue 1
Peter D. Krueger, Huihong Qiao, Matthew G. Lassen, Young S. Hahn
T Cell Receptors for Gene Transfer in Adoptive T Cell Therapy Critical Reviews™ in Immunology, Vol.39, 2019, issue 2
David M. Kranz, Preeti Sharma
The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune Critical Reviews™ in Immunology, Vol.40, 2020, issue 2
Salem Chouaib

Dernier numéro

The Value of Systemic Immune-Inflammation Index and T Cell Subsets in the Severity and Prognosis of Sepsis Hao Zhou MiRNA let-7d-5p Alleviates Inflammatory Responses by Targeting Map3k1 and Inactivating ERK/p38 MAPK Signaling in Microglia Fan Fang, Cheng Chen Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang Effect of the p-Estrogen Receptor at Serine on Its Function and Breast Growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang

Prochains articles

Identification of key chondrocyte apoptosis-related genes in osteoarthritis based on weighted gene co-expression network analysis and experimental verification Wei Wang, Junyi Hong, Tianyi Cao, Fusheng Ye, Junwei Gao, Shumei Qin Anoikis and Mitophagy-Related Gene Signature for Predicting the Survival and Tumor Cell Progression in Colon Cancer Jian Shen, Minzhe Li Exploring the mechanism of Isoforskolin against asthma based on network pharmacology and experimental verification Yan Fang, Shibo Sun, Chuang Xiao, Min Li, Yuanyuan Zheng, Anju Zu, Zhuang Luo Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain